183 related articles for article (PubMed ID: 23190095)
1. Keep your eyes open: challenges and opportunities in ophthalmic therapeutics.
Wang S
Future Med Chem; 2012 Nov; 4(17):2119-21. PubMed ID: 23190095
[No Abstract] [Full Text] [Related]
2. Ocular Therapeutics: Drug Delivery and Pharmacology.
Dickmann L
Mol Pharm; 2016 Sep; 13(9):2875-6. PubMed ID: 27596048
[No Abstract] [Full Text] [Related]
3. A New Vision for the Eye: Unmet Ocular Drug Delivery Needs.
Rivers HM; Ray Chaudhuri S; Shah JC; Mittal S
Pharm Res; 2015 Sep; 32(9):2814-23. PubMed ID: 26055402
[No Abstract] [Full Text] [Related]
4. Eyes on new product development: ophthalmic drug delivery.
Novack GD
J Ocul Pharmacol Ther; 2013 Mar; 29(2):90-1. PubMed ID: 23485090
[No Abstract] [Full Text] [Related]
5. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2017; 33(1):1-2. PubMed ID: 28080222
[No Abstract] [Full Text] [Related]
6. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2017 Mar; 33(2):65. PubMed ID: 28099041
[No Abstract] [Full Text] [Related]
7. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2017 Apr; 33(3):129-131. PubMed ID: 28384030
[No Abstract] [Full Text] [Related]
8. Eyes on new product development.
Novack GD
J Ocul Pharmacol Ther; 2013 Sep; 29(7):611. PubMed ID: 23981251
[No Abstract] [Full Text] [Related]
9. Drug delivery to the eye: current trends and future perspectives.
Behar-Cohen F
Ther Deliv; 2012 Oct; 3(10):1135-7. PubMed ID: 23116006
[No Abstract] [Full Text] [Related]
10. Pharmaceutical Emulsions: A Viable Approach for Ocular Drug Delivery.
Bisen AC; Srivastava S; Mishra A; Sanap SN; Biswas A; Choudhury AD; Dubey A; Gupta NM; Yadav KS; Mugale MN; Bhatta RS
J Ocul Pharmacol Ther; 2024 Jun; 40(5):261-280. PubMed ID: 38654153
[No Abstract] [Full Text] [Related]
11. Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations.
Shen J; Lu GW; Hughes P
Pharm Res; 2018 Sep; 35(11):217. PubMed ID: 30255364
[TBL] [Abstract][Full Text] [Related]
12. Polymer-based carriers for ophthalmic drug delivery.
Imperiale JC; Acosta GB; Sosnik A
J Control Release; 2018 Sep; 285():106-141. PubMed ID: 29964135
[TBL] [Abstract][Full Text] [Related]
13. Ophthalmic opportunities for the medicinal chemist.
Kador PF
Future Med Chem; 2012 Nov; 4(17):2127-9. PubMed ID: 23190097
[No Abstract] [Full Text] [Related]
14. Eyes on new product development.
Novack GD
J Ocul Pharmacol Ther; 2012 Dec; 28(6):557-8. PubMed ID: 23167518
[No Abstract] [Full Text] [Related]
15. Ocular drug delivery.
Goepferich A
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):157. PubMed ID: 26004820
[No Abstract] [Full Text] [Related]
16. Are contact lenses the solution for effective ophthalmic drug delivery?
Bengani L; Chauhan A
Future Med Chem; 2012 Nov; 4(17):2141-3. PubMed ID: 23190101
[No Abstract] [Full Text] [Related]
17. Sustained transscleral drug delivery.
Barocas VH; Balachandran RK
Expert Opin Drug Deliv; 2008 Jan; 5(1):1-10. PubMed ID: 18095925
[TBL] [Abstract][Full Text] [Related]
18. Ophthalmic Drug Discovery and Development.
Gukasyan HJ; Hailu S; Karami TK
Pharm Res; 2019 Mar; 36(5):69. PubMed ID: 30887132
[No Abstract] [Full Text] [Related]
19. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2016 Mar; 32(2):65-6. PubMed ID: 26863523
[No Abstract] [Full Text] [Related]
20. Transporters and receptors in ocular drug delivery: opportunities and challenges.
Dey S; Mitra AK
Expert Opin Drug Deliv; 2005 Mar; 2(2):201-4. PubMed ID: 16296747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
